(Q40360157)

19 September 2017

Methotrexate in psoriasis. A brief review of indications, usage, and complications of methotrexate therapy (English)

1 reference

19 September 2017

1 reference

Hanno R

1

1 reference

19 September 2017

Gruber GG

series ordinal

2

1 reference

19 September 2017

Owen LG

series ordinal

3

1 reference

19 September 2017

Callen JP

series ordinal

4

1 reference

19 September 2017

language of work or name

English

0 references

publication date

1 February 1980

1 reference

Journal of the American Academy of Dermatology

19 September 2017

1 reference

19 September 2017

2

1 reference

19 September 2017

171-174

1 reference

19 September 2017

2

1 reference

The clinical pharmacology of methotrexate.new applications of an old drug

19 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2880%2980398-7

7 January 2021

Effect of aminopterin on epithelial tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2880%2980398-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0190-9622%2880%2980398-7

1 reference

7 January 2021

Abnormal cell proliferation in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2880%2980398-7

7 January 2021

The cell cycle in psoriasis: a reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2880%2980398-7

7 January 2021

Selective Action of Methotrexate on Psoriatic Epidermal Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2880%2980398-7

7 January 2021

Biological and Biochemical Actions of Methotrexate in Psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2880%2980398-7

7 January 2021

Effects of methotrexate on proliferation of human keratinocytes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2880%2980398-7

7 January 2021

Methotrexate induced liver disease in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2880%2980398-7

7 January 2021

Effects of methotrexate on the liver in psoriasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2880%2980398-7

7 January 2021

A prospective study of the effects of weekly oral methotrexate on liver biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2880%2980398-7

7 January 2021

Liver Damage due to Methotrexate in Patients with Psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2880%2980398-7

7 January 2021

Liver Disease Associated With Methotrexate Treatment of Psoriatic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2880%2980398-7

7 January 2021

Use of methotrexate in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2880%2980398-7

7 January 2021

Methotrexate pneumonitis in a psoriatic

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2880%2980398-7

7 January 2021

Methotrexate-induced pneumonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2880%2980398-7

7 January 2021

Progressive interstitial lung disease from prolonged methotrexate therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2880%2980398-7

7 January 2021

Renal toxicity of methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2880%2980398-7

7 January 2021

Letter: Renal function in methotrexate treated psoriatics

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2880%2980398-7

7 January 2021

Is methotrexate therapy for psoriasis carcinogenic? A modified retrospective-prospective analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2880%2980398-7

7 January 2021

10.1016/S0190-9622(80)80398-7

Identifiers

DOI

1 reference

19 September 2017

1 reference